Literature DB >> 7758512

Echocardiographic evaluation of the development of aortic valve prolapse in supracristal ventricular septal defect.

K Mori1, S Matsuoka, K Tatara, Y Hayabuchi, M Nii, Y Kuroda.   

Abstract

UNLABELLED: The development and timing of aortic valve prolapse (AoVP) and aortic regurgitation (AR) was studied by two-dimensional echocardiography in 99 consecutive patients with supracristal ventricular septal defect (VSD). Thirty patients (30%) had aortic valve prolapse (VSD + AoVP group), and 31 patients (31%) had AoVP with AR (VSD + AoVP + AR group). In the VSD + AoVP group, AoVP was detected first by echocardiography at the age of 6.8 +/- 4.2 years (mean +/- SD). In the VSD + AoVP + AR group, the interval from detection of AoVP to the appearance of AR was 3.4 +/- 2.0 years. The configuration of the prolapsed aortic valve was echocardiographically classified into two types: tear-drop type (small) prolapse and box type (large) prolapse. The frequency of tear-drop type prolapse was not significantly different between VSD + AoVP and VSD + AoVP + AR groups (43% versus 32%, respectively), indicating that even minor AoVP can result in AR. Four infants (4%) had AoVP at the ages of 1, 5, 7, and 11 months, respectively. All infants had tear-drop type prolapse. Two infants developed AR by colour flow mapping at the ages of 3 and 11 months, and the interval from prolapse to AR was only 2 and 4 months, respectively.
CONCLUSION: Aortic valce involvement can develop under the age of 1 year in supracristal VSD. Regular evaluation by two-dimensional echocardiography with colour flow mapping is important in the follow-up of children with supracristal VSD.

Entities:  

Mesh:

Year:  1995        PMID: 7758512     DOI: 10.1007/BF01954266

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  Diagnostic importance of aortography in conal ventricular-septal defect.

Authors:  K Tatsuno; M Ando; A Takao; K Hatsune; S Konno
Journal:  Am Heart J       Date:  1975-02       Impact factor: 4.749

2.  Cross-sectional echocardiography in the evaluation of aortic valve prolapse associated with ventricular septal defect.

Authors:  B G Craig; J F Smallhorn; P Burrows; G A Trusler; R D Rowe
Journal:  Am Heart J       Date:  1986-10       Impact factor: 4.749

3.  Subpulmonic ventricular septal defect associated with aortic insufficiency.

Authors:  I Dimich; L Steinfeld; R S Litwak; S Park; N Silvers
Journal:  Am J Cardiol       Date:  1973-09-07       Impact factor: 2.778

4.  Doubly committed subarterial ventricular septal defects: echocardiographic features and surgical implications.

Authors:  K G Schmidt; S C Cassidy; N H Silverman; P Stanger
Journal:  J Am Coll Cardiol       Date:  1988-12       Impact factor: 24.094

5.  Color Doppler evaluation of valvular regurgitation in normal subjects.

Authors:  K Yoshida; J Yoshikawa; M Shakudo; T Akasaka; Y Jyo; S Takao; K Shiratori; K Koizumi; F Okumachi; H Kato
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

6.  Natural history of subarterial infundibular ventricular septal defect.

Authors:  K Momma; K Toyama; A Takao; M Ando; M Nakazawa; K Hirosawa; Y Imai
Journal:  Am Heart J       Date:  1984-11       Impact factor: 4.749

  6 in total
  3 in total

1.  Right coronary cusp prolapse resembling subpulmonic stenosis in an old adult patient with ventricular septal defect.

Authors:  Myeong Gun Kim; Wook-Jin Chung; Chang Hyu Choi; Jeonggeun Moon; Mi-Seung Shin; Seung Hwan Han; Eak Kyun Shin
Journal:  J Cardiovasc Ultrasound       Date:  2011-12-27

2.  Doubly committed Subarterial Ventricular Septal defect repair: An experience of 51 cases.

Authors:  Tariq Waqar; Muhammad Farhan Ali Rizvi; Ahmad Raza Baig
Journal:  Pak J Med Sci       Date:  2017 Sep-Oct       Impact factor: 1.088

3.  Transcatheter closure of ventricular septal defect in aortic valve prolapse and aortic regurgitation.

Authors:  Sanjiban Ghosh; Anuradha Sridhar; Neville Solomon; Muthukumaran Sivaprakasham
Journal:  Indian Heart J       Date:  2017-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.